SCHEMBL6888729

SCHEMBL6888729

COc1cc2c3c(c4c(c2cc1N1CCOCC1)-c1ccccc1C4)OC(c1ccccc1)(c1ccc(N(C)C)cc1)C=C3

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.32
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
HRH2 P25021 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
MAPT P10636 3/20 0.31
TDP1 Q9NUW8 3/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
AGER Q15109 1/20 0.31
HSD17B10 Q99714 1/20 0.31
RECQL P46063 1/20 0.30
USP2 O75604 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6889466 0.93 LPAR5 (0.30)
SCHEMBL6890929 0.92 STK10 (0.35) DRD2DRD4HRH2HRH1DRD3
SCHEMBL6888923 0.87 STK10 (0.33) MAPTTDP1L3MBTL1KDM4EMEN1
SCHEMBL6889518 0.85 BCHE (0.32) BCHEDRD2DRD4HRH2HRH1
SCHEMBL5101461 0.82 MEN1 (0.33) MAPTKDM4EMEN1KMT2A
SCHEMBL6881954 0.81 PRKDC (0.34) BCHEMAPTTDP1L3MBTL1KDM4E
SCHEMBL6889478 0.79
SCHEMBL6888011 0.77 STK10 (0.34) DRD2DRD4HRH2HRH1DRD3
SCHEMBL13766140 0.77 DRD2 (0.36) DRD2
SCHEMBL13880288 0.76 STK10 (0.36) MAPTTDP1L3MBTL1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686468-B2 FOR USE IN SYNTHETIC RESINS TO OBTAIN VIOLET TO BLUE TINTS; USED IN PHOTOTROPIC GLASSES OPTISCHE WERKE G. RODENSTOCK (DE) 2004-02-03 US claimed
EP-1235823-B1 H-ANNELLATED BENZO [F]CHROMENES RODENSTOCK OPTIK G (DE) 2003-07-16 EP claimed
US-20030040623-A1 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses RODENSTOCK GMBH (DE) 2003-02-27 US claimed
US-6686468-B2 FOR USE IN SYNTHETIC RESINS TO OBTAIN VIOLET TO BLUE TINTS; USED IN PHOTOTROPIC GLASSES OPTISCHE WERKE G. RODENSTOCK (DE) 2004-02-03 US disclosed
EP-1235823-B1 H-ANNELLATED BENZO [F]CHROMENES RODENSTOCK OPTIK G (DE) 2003-07-16 EP disclosed
US-20030040623-A1 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses RODENSTOCK GMBH (DE) 2003-02-27 US disclosed
EP-1235823-A1 H-ANNELLATED BENZO F]CHROMENES Optische Werke G. Rodenstock (DE) 2002-09-04 EP disclosed
WO-2002022594-A1 H-ANNELLATED BENZO[F]CHROMENES OPTISCHE WERKE G. RODENSTOCK (DE) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030040623-A1 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses NR2E3, RB1, BRD7 BCHE 756/4885DRD2 309/4885DRD4 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.